Kraig Biocraft Laboratories Inc (KBLB)

[GTman1]

It's essentially just like our $1mm bridge financing deal that we did March 2019, except more than 10 times bigger. It will also likely be at a more shareholder friendly shareprice considering the shareprice is more than double than where it was last year in march 2019. This means it's less dilution than if it was done last year.

Also, it is with an established investment bank, rather than a Vietnamese entity.

Also, the $1mm last year was to keep operations going. This deal is for expansion and (according to Kims words at the ASM) much needed marketing. It should be enough to get us through to revenues.